ME00562A - Novel salt form of pantoprazole - Google Patents

Novel salt form of pantoprazole

Info

Publication number
ME00562A
ME00562A MEP-847/08A MEP84708A ME00562A ME 00562 A ME00562 A ME 00562A ME P84708 A MEP84708 A ME P84708A ME 00562 A ME00562 A ME 00562A
Authority
ME
Montenegro
Prior art keywords
pantoprazole
salt form
novel salt
novel
relates
Prior art date
Application number
MEP-847/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Bernhard Kohl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7881823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00562(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of ME00562B publication Critical patent/ME00562B/me
Publication of ME00562A publication Critical patent/ME00562A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Gases (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Detergent Compositions (AREA)
  • Manufacture And Refinement Of Metals (AREA)
MEP-847/08A 1998-08-18 1999-08-12 Novel salt form of pantoprazole ME00562A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19843413A DE19843413C1 (de) 1998-08-18 1998-08-18 Neue Salzform von Pantoprazol
PCT/EP1999/005928 WO2000010995A1 (en) 1998-08-18 1999-08-12 Novel salt form of pantoprazole
YUP-113/01A RS50071B (sr) 1998-08-18 1999-08-12 Novi oblik soli pantoprazola

Publications (2)

Publication Number Publication Date
ME00562B ME00562B (me) 2011-12-20
ME00562A true ME00562A (en) 2011-12-20

Family

ID=7881823

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-847/08A ME00562A (en) 1998-08-18 1999-08-12 Novel salt form of pantoprazole

Country Status (33)

Country Link
US (2) US6410569B1 (ru)
EP (1) EP1105386B1 (ru)
JP (1) JP2002523411A (ru)
KR (1) KR100657835B1 (ru)
CN (1) CN1146558C (ru)
AT (1) ATE219074T1 (ru)
AU (1) AU761715B2 (ru)
BG (1) BG65255B1 (ru)
BR (1) BR9914288A (ru)
CA (1) CA2341031C (ru)
CZ (1) CZ293734B6 (ru)
DE (3) DE19843413C1 (ru)
DK (1) DK1105386T3 (ru)
EA (1) EA004431B1 (ru)
EE (1) EE04278B1 (ru)
ES (1) ES2178896T3 (ru)
HK (1) HK1037616A1 (ru)
HR (1) HRP20010117B1 (ru)
HU (1) HU226618B1 (ru)
IL (3) IL141157A0 (ru)
ME (1) ME00562A (ru)
MX (1) MXPA01001758A (ru)
NO (1) NO319782B1 (ru)
NZ (1) NZ509761A (ru)
PL (1) PL198801B1 (ru)
PT (1) PT1105386E (ru)
RS (1) RS50071B (ru)
SI (1) SI1105386T1 (ru)
SK (1) SK285105B6 (ru)
TR (1) TR200100287T2 (ru)
UA (1) UA58605C2 (ru)
WO (1) WO2000010995A1 (ru)
ZA (1) ZA200100934B (ru)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
JP2006514108A (ja) * 2002-12-19 2006-04-27 テバ ファーマシューティカル インダストリーズ リミティド パントプラゾールナトリウムの固体状態、それらの調製方法、及び公知のパントプラゾールナトリウム水和物の調製方法
WO2004098599A2 (en) * 2003-05-06 2004-11-18 Altana Pharma Ag Proton pump inhibitors for the treatment of lower abdominal disorders
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) * 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CN1791406A (zh) * 2003-05-19 2006-06-21 普利瓦研究与发展有限公司 5－(二氟甲氧基)－2－[[(3,4－二甲氧基－2－吡啶基)甲基]亚硫酰基]－1h－苯并咪唑(泮托拉唑)钠水络合物的固态形式
US7683177B2 (en) * 2003-06-10 2010-03-23 Teva Pharmaceutical Industries Ltd Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
AU2004260832A1 (en) * 2003-07-23 2005-02-10 Nycomed Gmbh Alkaline salts of proton pump inhibitors
CN100457104C (zh) * 2003-07-23 2009-02-04 尼科梅德有限责任公司 质子泵抑制剂的碱性盐
CA2554260A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
WO2005074931A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations comprising (s) -pantoprazole
WO2005074898A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
WO2005074930A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
WO2005074932A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag The use of (s) - pantoprazole magnesium for the treatment of airway disorders
EP1716136A1 (en) * 2004-02-11 2006-11-02 Ulkar Kimya Sanayii Ve Ticaret A.S. Pyridine benzimidazole sulfoxides of high purity
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
CA2565083C (en) * 2004-05-07 2014-07-08 Altana Pharma Ag Novel pharmaceutical dosage form and manufacturing process
WO2007041790A1 (en) * 2005-10-14 2007-04-19 Jon Pty Limited Salts of proton pump inhibitors and process for preparing same
WO2007146341A2 (en) 2006-06-12 2007-12-21 Teva Pharmaceutical Industries Ltd. Amorphous and crystalline forms of pantoprazole magnesium salt
US20080177076A1 (en) * 2006-11-06 2008-07-24 Lilach Hedvanti Processes for preparing substantially pure pantoprazole magnesium
WO2017114898A1 (en) * 2015-12-30 2017-07-06 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of pantoprazole sodium sesquihydrate
EP3187494A1 (en) * 2015-12-30 2017-07-05 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of pantoprazole sodium sesquihydrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
DE4018642C2 (de) * 1990-06-11 1993-11-25 Byk Gulden Lomberg Chem Fab Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol

Also Published As

Publication number Publication date
DE19843413C1 (de) 2000-03-30
US20020188008A1 (en) 2002-12-12
KR100657835B1 (ko) 2006-12-15
DE69901840T2 (de) 2003-05-22
ZA200100934B (en) 2002-03-04
NO20010718D0 (no) 2001-02-12
YU11301A (sh) 2003-12-31
CN1146558C (zh) 2004-04-21
CZ293734B6 (cs) 2004-07-14
EE04278B1 (et) 2004-04-15
SI1105386T1 (en) 2002-12-31
NO20010718L (no) 2001-02-12
UA58605C2 (ru) 2003-08-15
JP2002523411A (ja) 2002-07-30
EP1105386B1 (en) 2002-06-12
SK2362001A3 (en) 2001-09-11
TR200100287T2 (tr) 2001-07-23
HRP20010117B1 (en) 2010-07-31
DE69901840D1 (de) 2002-07-18
BG65255B1 (bg) 2007-10-31
DE122005000049I2 (de) 2007-03-29
SK285105B6 (sk) 2006-06-01
IL141157A0 (en) 2002-02-10
MXPA01001758A (es) 2002-04-17
BG105173A (en) 2001-11-30
IL141157A (en) 2007-06-17
AU761715B2 (en) 2003-06-05
RS50071B (sr) 2009-01-22
DK1105386T3 (da) 2002-09-30
CA2341031C (en) 2006-04-04
BR9914288A (pt) 2001-06-19
CZ2001621A3 (cs) 2001-08-15
ES2178896T3 (es) 2003-01-01
HUP0103257A2 (hu) 2002-02-28
PT1105386E (pt) 2002-11-29
PL345993A1 (en) 2002-01-14
ME00562B (me) 2011-12-20
ATE219074T1 (de) 2002-06-15
US6686379B2 (en) 2004-02-03
DE122005000049I1 (de) 2006-12-28
EP1105386A1 (en) 2001-06-13
NZ509761A (en) 2003-08-29
HRP20010117A2 (en) 2002-02-28
CA2341031A1 (en) 2000-03-02
NO319782B1 (no) 2005-09-12
IL141328A0 (en) 2002-03-10
EA004431B1 (ru) 2004-04-29
US6410569B1 (en) 2002-06-25
HK1037616A1 (en) 2002-02-15
PL198801B1 (pl) 2008-07-31
AU5515699A (en) 2000-03-14
HU226618B1 (en) 2009-04-28
EE200100054A (et) 2002-06-17
EA200100208A1 (ru) 2001-08-27
CN1318065A (zh) 2001-10-17
HUP0103257A3 (en) 2003-01-28
KR20010072487A (ko) 2001-07-31
WO2000010995A1 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
ME00562A (en) Novel salt form of pantoprazole
IS2170B (is) Sýklópentanóindól, efnablöndur sem innihalda slíkefnasambönd og meðhöndlunaraðferðir
ID27092A (id) Pembuatan ftalat anhidrida
ID29021A (id) Komposisi galantamina pelepasan terkontrol
DE69919700D1 (de) Überbrückte indenopyrrolocarbazole
FR2773169B1 (fr) Composition amelioree en bloc solide alcalin
ATE236899T1 (de) Neue kristallinische form des kaliumsalzes des (s)-omeprazols
MXPA03004904A (es) Proceso para la preparacion de alquilarilsulfonatos.
IT1298535B1 (it) Procedimento per la produzione di gamma-butirrolattone
YU11401A (sh) Lokalne farmaceutske kompozicije koje sadrže nimesulid
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
ATE265846T1 (de) Butorphanol enthaltende formulierungen mit verzögerter freisetzung
FI981810A0 (fi) Menetelmä alkuainepitoisuuksien määrittämiseksi
ID24327A (id) Produksi senyawa-senyawa avermektin
PT1088010E (pt) Producao de poliolefinas
DE50103684D1 (de) Verfahren zur erhöhung der inneren stabilität von natriumpercarbonat
DK1098878T3 (da) Bispiperidiner som antitrombotiske midler
ITRM20010309A0 (it) Procedimento per la produzione di composti perfluoro-organici mediante florurazione elettrochimica.
BR0110800A (pt) Polipeptìdeos antiangiogênicos
TR200003083T2 (tr) CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.
FR2848287B1 (fr) Bloc autonome d'eclairage de securite.
IT1318631B1 (it) Procedimento per la produzione di alfa-olefine.